SCHG vs XLV
Schwab US Large-Cap Growth ETF vs Health Care Select Sector SPDR Fund
- • SCHG has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | SCHG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.38% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $55.63B | $37.88B |
YTD return | 3.78% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.17 | 0.58 |
P/E ratio | 33.55 | 26.68 |
Last price | $33.89 | $144.72 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHG top holdings
| NVDA | NVIDIA Corp | 12.47% |
| AAPL | Apple Inc | 9.72% |
| MSFT | Microsoft Corp | 7.73% |
| AMZN | Amazon.com Inc | 6.30% |
| GOOGL | Alphabet Inc Class A | 4.99% |
| AVGO | Broadcom Inc | 4.62% |
| GOOG | Alphabet Inc Class C | 3.98% |
| META | Meta Platforms Inc Class A | 3.70% |
| TSLA | Tesla Inc | 3.39% |
| LLY | Eli Lilly and Co | 2.38% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About SCHG
SCHG (Schwab US Large-Cap Growth ETF) is Large-cap US growth at low cost. Managed by Schwab, the fund carries $55.6B in assets under management, an expense ratio of 0.04%, a dividend yield of 0.38%. Its largest holding is NVIDIA Corp (NVDA), which represents 12.5% of the portfolio. Real Estate is the fund's largest sector exposure at 0.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.